Recovery ⏱ Half-life: Short. Experimental

Vesilute

Vesilute (Bladder Peptide Bioregulator)

Updated March 15, 2026

Evidence at a Glance

Regulatory statusExperimental
Khavinson Glu-Asp bladder/urinary bioregulator; not an approved drug anywhere; only small Russian reports
Human evidenceAnecdotal only
Animal evidenceLimited

A short Khavinson 'bioregulator' peptide whose bladder and urinary claims rest on small, uncontrolled Russian reports with no independent Western replication.

What the research does not support

  • It has no FDA approval and is not a validated treatment for overactive bladder, prostate, or urinary conditions.
  • The proposed gene-regulating 'epigenetic' mechanism has not been reproduced by independent laboratories.
  • The human data amount to a single small non-randomized study, which cannot establish real-world efficacy.
  • It does not regenerate or 'reset' aging bladder tissue as marketing sometimes implies.
Half-Life
Short.
Mol. Weight
Peptide complex

What is Vesilute?

Vesilute is a peptide bioregulator designed to support bladder and urinary tract tissue function through targeted gene expression modulation in urothelial and smooth muscle cells.

Research Applications

Bladder function, overactive bladder research, interstitial cystitis, and urinary tract aging.

Dosage Information (Research Use)

Capsules: 1-2 daily for 10-30 day courses. Research use only.

Reconstitution & Handling

Capsules taken orally.

Half-Life & Pharmacokinetics

Short.

Reported Observations in Literature

Generally well-tolerated.

Key Research References

  • Khavinson VK. “Peptide Bioregulators.” 2003

How Vesilute Works

Vesilute modulates gene expression in bladder urothelial cells and detrusor smooth muscle, supporting bladder wall integrity and normal urinary function signaling.

Research Findings

Studied for overactive bladder, interstitial cystitis models, and age-related urinary function decline.

Dosage & Administration

Capsules: 1-2 daily for 10-30 day courses. Research use only.

Safety & Side Effects

Generally well-tolerated.

Important: All safety information is derived from published research, primarily animal studies. No controlled human clinical trial data exists unless explicitly noted. This compound is sold for research purposes only.

Quick Facts

Sequence Short peptide bioregulator complex targeting bladder tissue
Molecular Weight Peptide complex
Half-Life Short.
Available Sizes 5mg, capsules
Storage Room temperature for capsules. Lyophilized: -20°C.

Key Research References

  • Khavinson VK. "Peptide Bioregulators." 2003

Related Peptides

View all →
Vosoritide
Recovery
FDA-approved modified C-type natriuretic peptide analog that promotes bone growth in children with achondroplasia.
View Profile →
KLOW
Recovery
KLOW is not a single compound. It is a trade name for a research blend of four peptides,…
View Profile → Buy Now
ARA-290
Recovery
EPO-derived peptide that activates tissue-protective innate repair receptor without stimulating red blood cell production.
View Profile → Buy Now